Department of Health and Social Care (DHSC) has issued a medicine supply notification for Clomifene (Clomid) 50mg tablets on Monday (5 June).
It said: "Sanofi will be out of stock of clomifene (Clomid) 50mg tablets from w/c 12 June 2023 until w/c 18 September 2023."
“Generic clomifene 50mg tablets remain available from Wockhardt who are able to partially uplift supplies until the end of July 2023. Unlicensed supplies of clomifene 50mg tablets may be sourced, lead times vary. Alternative medicines for use in infertility remain available,” it added.
The specialist importers-Orifam and Target Healthcare have confirmed to DHSC they can source unlicensed clomifene 50mg tablets.
“If there is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems an EPS prescription for unlicensed clomifene 50mg tablets cannot be issued,” said Community Pharmacy England.
“Where a prescriber wishes to prescribe a specially manufactured or imported product, an FP10 paper prescription should be issued as ‘ clomifene 50mg tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special with the information on Amount dispensed over pack size used; Invoice price per pack size from which the order was supplied lessany discount or rebate; Manufacturers’/importers’ MHRA licence number; Batch number of the product supplied; and SP.”
